A Machine-Learning-Based Drug Repurposing Approach Using Baseline Regularization.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Methods in molecular biology

• Publication date

  2018-12-14

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1007/978-1-4939-8955-3_15PMID 30547447PMCID PMC6296259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Verapamil in Diabetes

  2017cited by this paper
• Pharmacovigilance via Baseline Regularization with Large-Scale Longitudinal Observational Data

  2017cited by this paper
• Hawkes Process Modeling of Adverse Drug Reactions with Longitudinal Observational Data

  2017cited by this paper
• Computational Drug Repositioning Using Continuous Self-Controlled Case Series

  2016cited by this paper
• Hypoglycemia Induced by Pregabalin.

  2016cited by this paper
• Baseline Regularization for Computational Drug Repositioning with Longitudinal Observational Data

  2016cited by this paper
• Hypoglycemia Induced by Pregabalin.

  2016cited by this paper
• Fused Lasso Screening Rules via the Monotonicity of Subdifferentials

  2015cited by this paper
• Multiple Self‐Controlled Case Series for Large‐Scale Longitudinal Observational Databases

  2013cited by this paper
• A Dynamic Programming Algorithm for the Fused Lasso and L0-Segmentation

  2013cited by this paper
• The Impact of Thiamine Treatment in the Diabetes Mellitus

  2012cited by this paper
• Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease

  2011cited by this paper
• Influence of atorvastatin on the pharmacokinetics and pharmacodynamics of glyburide in normal and diabetic rats.

  2011cited by this paper
• Regularization Paths for Generalized Linear Models via Coordinate Descent.

  2010cited by this paper
• Strong rules for discarding predictors in lasso‐type problems

  2010cited by this paper
• Drug safety surveillance using de-identified EMR and claims data: issues and challenges

  2010cited by this paper
• The solution path of the generalized lasso

  2010cited by this paper
• Convergence of a Block Coordinate Descent Method for Nondifferentiable Minimization

  2001cited by this paper
• [Interaction between converting enzyme inhibitors and hypoglycemic sulfonamides or insulin].

  1998cited by this paper
• Regression Shrinkage and Selection via the Lasso

  1996cited by this paper
• Exploratory Data Analysis.

  1978cited by this paper

• Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.

  2024cites this paper
• Indication Finding: a novel use case for representation learning

  2024cites this paper
• Network Based Identification of Holistic Drug Target for Parkinson Disease and Deep Learning assisted Drug Repurposing

  2022cites this paper
• Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics

  2021cites this paper
• An Analytical Review of Computational Drug Repurposing

  2021cites this paper
• Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery

  2021cites this paper
• Modern computational intelligence based drug repurposing for diabetes epidemic.

  2021cites this paper
• The use of real-world data in drug repurposing

  2021cites this paper
• An introduction to machine learning and analysis of its use in rheumatic diseases

  2021cites this paper
• Adverse drug reaction discovery from electronic health records with deep neural networks

  2020cites this paper
• Drug targets for COVID-19 therapeutics: Ongoing global efforts

  2020cites this paper
• Framework for identifying drug repurposing candidates from observational healthcare data

  2020cites this paper
• Drug targets for COVID-19 therapeutics: Ongoing global efforts

  2020cites this paper
• Applications of artificial intelligence in drug development using real-world data

  2020cites this paper
• FMT and Microbial Medical Products: Generating High-Quality Evidence through Good Governance

  2019cites this paper
• Artificial Intelligence for Drug Toxicity and Safety.

  2019cites this paper
• A systematic computational analysis of human matrix metalloproteinase 13 (MMP-13) crystal structures and structure-based identification of prospective drug candidates as MMP-13 inhibitors repurposable for osteoarthritis

  2019cites this paper